Welcome to the InfoSci Platform
Reference Hub2
Risk Identification of Diabetic Macular Edema Using E-Adoption of Emerging Technology

Risk Identification of Diabetic Macular Edema Using E-Adoption of Emerging Technology

Amit Kumar, Anand Shanker Tewari
Copyright: © 2022 |Volume: 14 |Issue: 3 |Pages: 20
ISSN: 1937-9633|EISSN: 1937-9641|EISBN13: 9781668478615|DOI: 10.4018/IJEA.310000
Cite Article Cite Article

MLA

Kumar, Amit, and Anand Shanker Tewari. "Risk Identification of Diabetic Macular Edema Using E-Adoption of Emerging Technology." IJEA vol.14, no.3 2022: pp.1-20. http://doi.org/10.4018/IJEA.310000

APA

Kumar, A. & Tewari, A. S. (2022). Risk Identification of Diabetic Macular Edema Using E-Adoption of Emerging Technology. International Journal of E-Adoption (IJEA), 14(3), 1-20. http://doi.org/10.4018/IJEA.310000

Chicago

Kumar, Amit, and Anand Shanker Tewari. "Risk Identification of Diabetic Macular Edema Using E-Adoption of Emerging Technology," International Journal of E-Adoption (IJEA) 14, no.3: 1-20. http://doi.org/10.4018/IJEA.310000

Export Reference

Mendeley
Favorite Full-Issue Download

Abstract

The accumulation of the blood leaks on the retina is known as diabetic macular edema (DME), which can result in irreversible blindness. Early diagnosis and therapy can stop DME. This study presents an e-adoption of emerging technology such as RadioDense model for detecting and classifying DME from retinal fundus images. The proposed model employs a modified version of DenseNet121, radiomics features, and the gradient boosting classifier. The authors evaluated many classifiers on the concatenated features. The efficacy of the classifier is determined by comparing each classifier's accuracy values. According to the evaluation results, the concatenated features extraction using gradient boosting classifier outperforms all other classifiers on the IDRiD dataset. For multi-class classification, the suggested electronic adoption of emerging technology such as RadioDense model outperformed these classifiers and attained an accuracy of 87.4%. It can help to decrease the strain of ophthalmologists diagnosing the DME during locking and unlocking the worldwide lockdown.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.